Abdulkader Puranwala
Stock Analyst at ICICI Securities
(3.43)
# 2,341
Out of 5,099 analysts
40
Total ratings
61.5%
Success rate
10.2%
Average return
Main Sectors:
Stocks Rated by Abdulkader Puranwala
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| NSE: ALKEM Alkem Laboratories Limited | Reiterated: Buy | ₹6,065 → ₹6,850 | ₹5,236 | +30.83% | 4 | May 28, 2026 | |
| NSE: APOLLOHOSP Apollo Hospitals Enterprise Limited | Reiterated: Buy | ₹8,840 → ₹8,820 | ₹8,440 | +4.50% | 3 | Feb 12, 2026 | |
| NSE: GLENMARK Glenmark Pharmaceuticals Limited | Reiterated: Sell | ₹1,570 → ₹1,640 | ₹2,408 | -31.89% | 3 | Feb 3, 2026 | |
| NSE: GLAND Gland Pharma Limited | Reiterated: Buy | ₹2,115 → ₹2,275 | ₹3,153 | -27.85% | 2 | Jan 29, 2026 | |
| NSE: AKUMS Akums Drugs and Pharmaceuticals Limited | Reiterated: Buy | ₹655.00 → ₹600.00 | ₹755.00 | -20.53% | 3 | Dec 22, 2025 | |
| NSE: SUNPHARMA Sun Pharmaceutical Industries Limited | Reiterated: Buy | ₹1,800 → ₹1,965 | ₹1,770 | +11.02% | 2 | Nov 6, 2025 | |
| NSE: NATCOPHARM NATCO Pharma Limited | Reiterated: Sell | ₹890.00 → ₹810.00 | ₹781.00 | n/a | 2 | Aug 14, 2025 | |
| NSE: METROPOLIS Metropolis Healthcare Limited | Reiterated: Buy | ₹600.00 | ₹568.10 | n/a | 1 | Aug 11, 2025 | |
| NSE: FORTIS Fortis Healthcare Limited | Upgraded: Hold | ₹855.00 | ₹785.55 | n/a | 1 | Aug 8, 2025 | |
| NSE: KIMS Krishna Institute of Medical Sciences Limited | Downgraded: Sell | ₹630.00 | ₹731.75 | n/a | 2 | Aug 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | ₹5,400 | ₹10,064 | n/a | 1 | Aug 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | ₹2,110 → ₹1,950 | ₹2,016 | n/a | 2 | Aug 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | ₹900.00 | ₹803.00 | n/a | 1 | Aug 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | ₹1,445 → ₹1,300 | ₹1,695 | n/a | 2 | Aug 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | ₹590.00 | ₹654.00 | n/a | 1 | Aug 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | ₹2,900 → ₹1,500 | ₹1,916 | n/a | 2 | Aug 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | ₹1,000 | ₹1,452 | n/a | 2 | Jul 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | ₹910.00 → ₹486.62 | ₹479.00 | n/a | 2 | Jul 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | ₹1,200 | ₹1,368 | n/a | 1 | Jul 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | ₹1,400 | ₹440.05 | n/a | 1 | Mar 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | ₹2,250 | ₹2,575 | n/a | 1 | Feb 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | ₹1,000 | ₹1,241 | n/a | 1 | Feb 6, 2025 |
Alkem Laboratories Limited
May 28, 2026
Reiterated: Buy
Price Target: ₹6,065 → ₹6,850
Current: ₹5,236
Upside: +30.83%
Apollo Hospitals Enterprise Limited
Feb 12, 2026
Reiterated: Buy
Price Target: ₹8,840 → ₹8,820
Current: ₹8,440
Upside: +4.50%
Glenmark Pharmaceuticals Limited
Feb 3, 2026
Reiterated: Sell
Price Target: ₹1,570 → ₹1,640
Current: ₹2,408
Upside: -31.89%
Gland Pharma Limited
Jan 29, 2026
Reiterated: Buy
Price Target: ₹2,115 → ₹2,275
Current: ₹3,153
Upside: -27.85%
Akums Drugs and Pharmaceuticals Limited
Dec 22, 2025
Reiterated: Buy
Price Target: ₹655.00 → ₹600.00
Current: ₹755.00
Upside: -20.53%
Sun Pharmaceutical Industries Limited
Nov 6, 2025
Reiterated: Buy
Price Target: ₹1,800 → ₹1,965
Current: ₹1,770
Upside: +11.02%
NATCO Pharma Limited
Aug 14, 2025
Reiterated: Sell
Price Target: ₹890.00 → ₹810.00
Current: ₹781.00
Upside: n/a
Metropolis Healthcare Limited
Aug 11, 2025
Reiterated: Buy
Price Target: ₹600.00
Current: ₹568.10
Upside: n/a
Fortis Healthcare Limited
Aug 8, 2025
Upgraded: Hold
Price Target: ₹855.00
Current: ₹785.55
Upside: n/a
Krishna Institute of Medical Sciences Limited
Aug 8, 2025
Downgraded: Sell
Price Target: ₹630.00
Current: ₹731.75
Upside: n/a
Aug 7, 2025
Reiterated: Sell
Price Target: ₹5,400
Current: ₹10,064
Upside: n/a
Aug 7, 2025
Reiterated: Hold
Price Target: ₹2,110 → ₹1,950
Current: ₹2,016
Upside: n/a
Aug 6, 2025
Reiterated: Hold
Price Target: ₹900.00
Current: ₹803.00
Upside: n/a
Aug 6, 2025
Upgraded: Buy
Price Target: ₹1,445 → ₹1,300
Current: ₹1,695
Upside: n/a
Aug 5, 2025
Reiterated: Hold
Price Target: ₹590.00
Current: ₹654.00
Upside: n/a
Aug 1, 2025
Reiterated: Hold
Price Target: ₹2,900 → ₹1,500
Current: ₹1,916
Upside: n/a
Jul 29, 2025
Reiterated: Sell
Price Target: ₹1,000
Current: ₹1,452
Upside: n/a
Jul 25, 2025
Reiterated: Buy
Price Target: ₹910.00 → ₹486.62
Current: ₹479.00
Upside: n/a
Jul 24, 2025
Reiterated: Hold
Price Target: ₹1,200
Current: ₹1,368
Upside: n/a
Mar 25, 2025
Initiated Coverage: Buy
Price Target: ₹1,400
Current: ₹440.05
Upside: n/a
Feb 17, 2025
Upgraded: Buy
Price Target: ₹2,250
Current: ₹2,575
Upside: n/a
Feb 6, 2025
Reiterated: Hold
Price Target: ₹1,000
Current: ₹1,241
Upside: n/a